Prosecution Insights
Last updated: April 19, 2026

Recursion Pharmaceuticals Inc.

9 pending office actions

Portfolio Summary

9
Total Pending OAs
6
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18937359 SYSTEMS AND METHODS FOR EVALUATING QUERY PERTURBATIONS TORRICO-LOPEZ, ALAN 3625 Non-Final OA Nov 05, 2024
18753906 DETERMINING PHENOMIC RELATIONSHIPS BETWEEN COMPOUNDS AND CELL PERTURBATIONS UTILIZING MACHINE LEARNING MODELS ROSSI, VY BUI 1685 Non-Final OA Jun 25, 2024
18750828 GENERATING LARGE-LANGUAGE-MODEL COMPATIBLE SEQUENTIAL ATTACHMENT-BASED FRAGMENT EMBEDDING MOLECULAR REPRESENTATIONS VILLENA, MARK 2658 Non-Final OA Jun 21, 2024
18390989 DETECTING ANALYSIS MODEL COMPATIBILITIES WITH COMPLEX EXPERIMENT DESIGNS TO GENERATE EXPERIMENT DESIGN AND ANALYSIS MODEL COMPATIBILITY GRAPHICAL USER INTERFACES CHOWDHURY, ZIAUL A. 2192 Final Rejection Dec 20, 2023
18505748 UTILIZING COMPOUND-PROTEIN MACHINE LEARNING REPRESENTATIONS TO GENERATE BIOACTIVITY PREDICTIONS NEGIN, RUSSELL SCOTT 1686 Final Rejection Nov 09, 2023
17439450 PROCESS CONTROL IN CELL BASED ASSAYS PLAYER, ROBERT AUSTIN 1686 Final Rejection Sep 15, 2021
17179043 DETERMINING THE GOODNESS OF A BIOLOGICAL VECTOR SPACE WONG, LUT 2127 Final Rejection Feb 18, 2021
17101545 HIGH THROUGHPUT GENE EDITING SYSTEM AND METHOD ARIETI, RUTH SOPHIA 1635 Final Rejection Nov 23, 2020
16538475 DESIGN OF MOLECULES HAYES, JONATHAN EDWARD 1685 Final Rejection Aug 12, 2019

Managing Recursion Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month